Author + information
- Received March 3, 2000
- Revision received May 22, 2000
- Accepted July 13, 2000
- Published online December 1, 2000.
- Ralf Zahn, MD∗,* (, )
- Rudolf Schiele, MD∗,
- Steffen Schneider, PhD∗,
- Anselm K Gitt, MD∗,
- Harm Wienbergen, MD∗,
- Karlheinz Seidl, MD∗,
- Claus Bossaller, MD†,
- Heinz J Büttner, MD‡,
- Martin Gottwik, MD§,
- Ernst Altmann, MD∥,
- Werner Rosahl, MD¶,
- Jochen Senges, MD, FACC∗,
- for the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and the Myocardial Infarction Registry (MIR) Study Groups
- ↵*Reprint requests and correspondence: Dr. Ralf Zahn, Herzzentrum Ludwigshafen, Department of Cardiology, Bremserstraβe 79, D - 67063 Ludwigshafen, Germany
We investigated changes in the clinical outcome of primary angioplasty and thrombolysis for the treatment of acute myocardial infarction (AMI) from 1994 to 1998.
Primary angioplasty for the treatment of AMI is a sophisticated technical procedure that requires experienced personnel and optimized hospital logistics. Growing experience with primary angioplasty in clinical routine and new adjunctive therapies may have improved the outcome over the years.
The pooled data of two German AMI registries: the Maximal Individual Therapy in AMI (MITRA) study and the Myocardial Infarction Registry (MIR) were analyzed.
Of 10,118 lytic eligible patients with AMI, 1,385 (13.7%) were treated with primary angioplasty, and 8,733 (86.3%) received intravenous thrombolysis. Patients characteristics were quite balanced between the two treatment groups, but there was a higher proportion of patients with a prehospital delay of >6 h in those treated with primary angioplasty. The proportion of an in-hospital delay of more than 90 min significantly decreased in patients treated with primary angioplasty over the years (p for trend = 0.015, multivariate odds ratio [OR] for each year of the observation period = 0.84, 95% confidence interval [CI]: 0.73– 0.96) but did not change significantly in patients treated with thrombolysis. Hospital mortality decreased significantly in the primary angioplasty group (p = 0.003 for trend; multivariate OR for each year = 0.73, 95% CI: 0.58– 0.93). However, for patients treated with thrombolysis, hospital mortality did not change significantly (p for trend 0.175, multivariate OR for each year: 1.02, 95% CI: 0.94– 1.11).
Compared with thrombolysis the clinical results of primary angioplasty for the treatment of AMI improved from 1994 to 1998. This indicates a beneficial effect of the growing experience and optimized hospital logistics of this technique over the years.
☆ Supported, in part, by AstraZeneca, Bristol Myers-Squibb, Ministerium für Gesundheit, Arbeit, Soziales des Landes Rheinland-Pfalz, Landesversicherungsanstalt Rheinland-Pfalz.
- Received March 3, 2000.
- Revision received May 22, 2000.
- Accepted July 13, 2000.
- American College of Cardiology